AVEO Oncology
AVEO
#7414
Rank
โ‚ฌ0.47 B
Marketcap
13,64ย โ‚ฌ
Share price
0.00%
Change (1 day)
185.19%
Change (1 year)

EPS for AVEO Oncology (AVEO)

EPS in 2022 (TTM): -0,78ย โ‚ฌ

According to AVEO Oncology 's latest financial reports the company's current EPS (TTM) is -0,76ย โ‚ฌ. In 2021 the company made an earnings per share (EPS) of -1,56ย โ‚ฌ a decrease over its 2020 EPS that were of -1,56ย โ‚ฌ.

EPS history for AVEO Oncology from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-0,78ย โ‚ฌ-50.3%
2021-1,56ย โ‚ฌ0.58%
2020-1,56ย โ‚ฌ-375.81%
20190,56ย โ‚ฌ-224%
2018-0,45ย โ‚ฌ-91.8%
2017-5,55ย โ‚ฌ52.5%
2016-3,64ย โ‚ฌ
2014-9,28ย โ‚ฌ
2012-23,92ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eli Lilly
LLY
28,10ย โ‚ฌ-3,777.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
15,81ย โ‚ฌ-2,169.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
2,15ย โ‚ฌ-380.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
42,73ย โ‚ฌ-5,692.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,11ย โ‚ฌ-638.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
12,61ย โ‚ฌ-1,750.00%๐Ÿ‡บ๐Ÿ‡ธ USA